Pharma Co. Clarus Hits Ch. 11 With Plan To Sell Sole Drug
Drug company Clarus Therapeutics filed for Chapter 11 protection in Delaware bankruptcy court, saying it is over $54 million in debt and is seeking to auction off its sole asset, a...To view the full article, register now.
Already a subscriber? Click here to view full article